Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?

被引:64
|
作者
Webster, Christopher P. [1 ]
Smith, Emma F. [1 ]
Shaw, Pamela J. [1 ]
De Vos, Kurt J. [1 ]
机构
[1] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Dept Neurosci, Sheffield, S Yorkshire, England
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2017年 / 10卷
基金
英国医学研究理事会; 欧盟地平线“2020”;
关键词
protein homeostasis; protein aggregation; amyotrophic lateral sclerosis (ALS); motor neuron disease; autophagy; chaperonins; unfolded protein response (UPR); proteostasis; MOTOR-NEURON DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; MUTANT SUPEROXIDE-DISMUTASE; ENDOPLASMIC-RETICULUM STRESS; VALOSIN-CONTAINING PROTEIN; DNA-BINDING PROTEIN; HEXANUCLEOTIDE REPEAT EXPANSION; HEREDITARY SPASTIC PARAPLEGIA; ER-MITOCHONDRIA ASSOCIATIONS; UBIQUITIN-PROTEASOME SYSTEM;
D O I
10.3389/fnmol.2017.00123
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Protein homeostasis (proteostasis), the correct balance between production and degradation of proteins, is essential for the health and survival of cells. Proteostasis requires an intricate network of protein quality control pathways (the proteostasis network) that work to prevent protein aggregation and maintain proteome health throughout the lifespan of the cell. Collapse of proteostasis has been implicated in the etiology of a number of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), the most common adult onset motor neuron disorder. Here, we review the evidence linking dysfunctional proteostasis to the etiology of ALS and discuss how ALS-associated insults affect the proteostasis network. Finally, we discuss the potential therapeutic benefit of proteostasis network modulation in ALS.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Therapeutic opportunities in amyotrophic lateral sclerosis
    Eisen, A
    NEUROLOGIST, 1996, 2 (02) : 85 - 95
  • [2] Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities
    Clark, Rosemary
    Blizzard, Catherine
    Dickson, Tracey
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (06) : 511 - 525
  • [3] Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities
    Soares, Pedro
    Silva, Catia
    Chavarria, Daniel
    Silva, Filomena S. G.
    Oliveira, Paulo J.
    Borges, Fernanda
    AGEING RESEARCH REVIEWS, 2023, 83
  • [4] Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations
    Park, Hee Ra
    Yang, Eun Jin
    DIAGNOSTICS, 2021, 11 (09)
  • [5] Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis
    Saini, Aniket
    Chawla, Pooja A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023,
  • [6] Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?
    Donnelly, Christopher J.
    Grima, Jonathan C.
    Sattler, Rita
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2014, 4 (06) : 417 - 437
  • [7] Therapeutic Approaches Targeting Protein Aggregation in Amyotrophic Lateral Sclerosis
    Malik, Ravinder
    Wiedau, Martina
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [8] Dysregulation of energy homeostasis in amyotrophic lateral sclerosis
    Guillot, Simon J.
    Bolborea, Matei
    Dupuis, Luc
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (05) : 773 - 780
  • [9] Misregulation of iron homeostasis in amyotrophic lateral sclerosis
    Gajowiak, Anna
    Stys, Agnieszka
    Starzynski, Rafal R.
    Staron, Robert
    Lipinski, Pawel
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 709 - 721
  • [10] Therapeutic advances in amyotrophic lateral sclerosis
    Louvel, E
    Hugon, J
    Doble, A
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (06) : 196 - 203